Reuters - Myriad Genetics Inc said it will stop
developing its drug for Alzheimer’s disease after a late-stage
trial of the drug, Flurizan, failed to meet primary goals.
Independent honest reviews of most effective natural herbal supplements
Reuters - Myriad Genetics Inc said it will stop
developing its drug for Alzheimer’s disease after a late-stage
trial of the drug, Flurizan, failed to meet primary goals.
The URI to TrackBack this entry is: http://herbal-review.com/2008/06/30/myriad-genetics-to-stop-developing-alzheimers-drug-reuters/trackback/
Please healthy :)
You must be logged in to post a comment.
|No results yet!
23 queries. 0.965 seconds